Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
Journal of Cellular Physiology|May 12, 2004
A role for lysyl oxidase regulation in the control of normal collagen deposition in differentiating osteoblast culturesHsiang-Hsi Hong, Nicole Pischon, Ronaldo B Santana, et al.
Practical Radiation Oncology|July 7, 2024
Treatment Terminations During Radiation Therapy: A 10-Year ExperienceJason D Nosrati, Daniel Ma, Beatrice Bloom, et al.
The Laryngoscope|September 17, 2016
Oncologic outcomes of selective neck dissection in HPV-related oropharyngeal squamous cell carcinomaJoseph Zenga, Ryan S Jackson, Evan M Graboyes, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|July 15, 2020
Human Papillomavirus-Associated Anogenital Pathology in Females With HPV-Positive Oropharyngeal Squamous Cell CarcinomaAlyssa Larish, Linda Yin, Gretchen Glaser, et al.
The Annals of Otology, Rhinology, and Laryngology|January 7, 2017
Mucosal Sparing Radiation Therapy in Resected Oropharyngeal CancerMauricio E Gamez, Michele Y Halyard, Michael L Hinni, et al.
Brain Communications|March 7, 2025
Phantom limb experience after brachial plexus anaesthesiaApolline Savarit, Violeta Pellicer Morata, Daniel Ma, et al.
Medical Physics|April 17, 2021
Magnetic resonance biomarkers in radiation oncology: The report of AAPM Task Group 294Kiaran P McGee, Ken-Pin Hwang, Daniel C Sullivan, et al.
Physics in Medicine and Biology|February 29, 2024
Automated target placement for VMAT lattice radiation therapy: enhancing efficiency and consistencyChristopher Deufel, Christopher Dodoo, James Kavanaugh, et al.
International Journal of Radiation Oncology, Biology, Physics|June 8, 2022
Long-Term Toxic Effects, Swallow Function, and Quality of Life on MC1273: A Phase 2 Study of Dose De-escalation for Adjuvant Chemoradiation in Human Papillomavirus-Positive Oropharyngeal CancerKatharine Price, Kathryn M Van Abel, Eric J Moore, et al.
The Lancet. Oncology|September 4, 2025
De-escalated adjuvant radiotherapy versus standard adjuvant treatment for human papillomavirus-associated oropharyngeal squamous cell carcinoma (MC1675): a phase 3, open-label, randomised controlled trialDaniel Ma, Katharine Price, Eric Moore, et al.
Pageof 8